Business Description
SMS Pharmaceuticals Ltd
ISIN : INE812G01025
Compare
Compare
Traded in other countries / regions
532815.India IPO Date
2007-02-28Description
SMS Pharmaceuticals Ltd is a drug manufacturing company. It is engaged in the manufacturing and sale of active pharmaceutical ingredients and their intermediates. Its product portfolio includes drugs for anti-ulcer, anti-fungal, anti-migraine, anti-diabetic, erectile dysfunction, anti-viral, among others.
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.14 | |||||
Equity-to-Asset | 0.52 | |||||
Debt-to-Equity | 0.52 | |||||
Debt-to-EBITDA | 2.17 | |||||
Interest Coverage | 4.21 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 4.9 | |||||
Beneish M-Score | -1.84 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 8.2 | |||||
3-Year EBITDA Growth Rate | -0.7 | |||||
3-Year EPS without NRI Growth Rate | -7.3 | |||||
3-Year FCF Growth Rate | 67.8 | |||||
3-Year Book Growth Rate | 9.3 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 72.08 | |||||
9-Day RSI | 70.4 | |||||
14-Day RSI | 68.84 | |||||
6-1 Month Momentum % | 85.61 | |||||
12-1 Month Momentum % | 112.7 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.61 | |||||
Quick Ratio | 0.9 | |||||
Cash Ratio | 0.12 | |||||
Days Inventory | 173.22 | |||||
Days Sales Outstanding | 88.81 | |||||
Days Payable | 99.9 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.09 | |||||
Dividend Payout Ratio | 0.04 | |||||
Forward Dividend Yield % | 0.12 | |||||
5-Year Yield-on-Cost % | 0.09 | |||||
Shareholder Yield % | -0.74 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 30.12 | |||||
Operating Margin % | 12.43 | |||||
Net Margin % | 7.72 | |||||
FCF Margin % | -0.28 | |||||
ROE % | 11.58 | |||||
ROA % | 5.91 | |||||
ROIC % | 8.74 | |||||
ROC (Joel Greenblatt) % | 13 | |||||
ROCE % | 14.83 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 50.38 | |||||
PE Ratio without NRI | 50.38 | |||||
Shiller PE Ratio | 52.3 | |||||
PEG Ratio | 71.97 | |||||
PS Ratio | 3.88 | |||||
PB Ratio | 5.37 | |||||
Price-to-Tangible-Book | 5.39 | |||||
Price-to-Operating-Cash-Flow | 57.38 | |||||
EV-to-EBIT | 32.28 | |||||
EV-to-EBITDA | 24.22 | |||||
EV-to-Revenue | 4.26 | |||||
EV-to-FCF | -1601.72 | |||||
Price-to-Projected-FCF | 7.13 | |||||
Price-to-Median-PS-Value | 2.54 | |||||
Price-to-Graham-Number | 3.72 | |||||
Price-to-Net-Current-Asset-Value | 79.71 | |||||
Earnings Yield (Greenblatt) % | 3.11 | |||||
FCF Yield % | -0.07 | |||||
Forward Rate of Return (Yacktman) % | 0.42 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
SMS Pharmaceuticals Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 7,383.753 | ||
EPS (TTM) (₹) | 6.75 | ||
Beta | 1.07 | ||
Volatility % | 43.39 | ||
14-Day RSI | 68.84 | ||
14-Day ATR (₹) | 15.498448 | ||
20-Day SMA (₹) | 304.85 | ||
12-1 Month Momentum % | 112.7 | ||
52-Week Range (₹) | 111.85 - 363.75 | ||
Shares Outstanding (Mil) | 84.65 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 8 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
SMS Pharmaceuticals Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
SMS Pharmaceuticals Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
SMS Pharmaceuticals Ltd Frequently Asked Questions
What is SMS Pharmaceuticals Ltd(NSE:SMSPHARMA)'s stock price today?
The current price of NSE:SMSPHARMA is ₹340.35. The 52 week high of NSE:SMSPHARMA is ₹363.75 and 52 week low is ₹111.85.
When is next earnings date of SMS Pharmaceuticals Ltd(NSE:SMSPHARMA)?
The next earnings date of SMS Pharmaceuticals Ltd(NSE:SMSPHARMA) is .
Does SMS Pharmaceuticals Ltd(NSE:SMSPHARMA) pay dividends? If so, how much?
The Dividend Yield %  of SMS Pharmaceuticals Ltd(NSE:SMSPHARMA) is 0.09% (As of Today), Highest Dividend Payout Ratio of SMS Pharmaceuticals Ltd(NSE:SMSPHARMA) was 0.13. The lowest was 0.04. And the median was 0.05. The  Forward Dividend Yield % of SMS Pharmaceuticals Ltd(NSE:SMSPHARMA) is 0.12%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |